COVAXIN Shows Impressive Safety And Immunogenicity Profile: Lancet Bharat Biotech and Indian Council of Medical Research made COVID-19 vaccine ‘COVAXIN’ Phase 1 trial data has been released. It has been showing safety, according to British medical journal Lancet. Watch the video for more.
